Phoenix, Arizona Correspondent

I spend a good deal of my working life in a hospital system, which means I have developed an allergy to the sentence, “The technology works.” That sentence may be accurate and still tell you very little about whether the technology makes life better. A machine can read an image, a model can identify a risk, and an algorithm can flag a patient. Those are important achievements. They are not the same as making sure the right person receives the right treatment, at the right time, without being injured by everything that happens along the way. I bring that distinction to the excitement surrounding de-extinction. I am fascinated by what scientists are attempting with the dodo. I am not embarrassed to say so. But the existence of an engineered bird would be the beginning of a demanding animal-care and ecological experiment, not the finish line of a historic triumph.

This week’s announcement from Colossal Biosciences is an excellent example of why precision matters. The company reports progress in reconstructing the dodo genome and has introduced an AI system called GenoMorph to identify genetic changes associated with the extinct bird’s anatomy. Reports describe work involving the Nicobar pigeon, a living relative, and collaboration with people in Mauritius on the possibility of future habitat restoration. That is serious scientific work, with potentially valuable applications beyond the dodo. It does not mean a dodo has hatched. It certainly does not mean a viable wild population is ready for release. We must resist the entertainment industry’s habit of collapsing research, clinical or biological feasibility, and successful real-world deployment into one triumphant moment. In health care we have paid for that confusion with money and, occasionally, with lives. Wildlife deserves a more sober standard.

Start with the animal, not the photograph. A genome is not a complete instruction manual that can be read without context. Genes operate through development, within cells and embryos, under influences that include maternal biology, nutrition, microbial exposure, and environmental signals. Scientists studying extinct organisms have the added difficulty of incomplete ancient DNA and limited knowledge about how particular sequences produced physical traits. AI can identify plausible associations, prioritize experiments, and compare surviving relatives. It cannot observe an extinct dodo feeding its offspring or guarantee that a set of edits will reproduce the physiology of the vanished bird. Anyone who has watched a diagnostic model perform beautifully on one hospital’s data and poorly on another’s should recognize the warning: a convincing prediction is not the same thing as a validated biological outcome.

A bird presents difficulties that differ from cloning a mammal. Investigators may need to edit reproductive precursor cells, produce viable gametes through a suitable living host, and establish a process that yields healthy offspring capable of reproducing. Each step brings its own failure modes. It would be irresponsible to describe the present scientific pathway as a straightforward matter of placing old DNA in a new egg. There are developmental barriers, compatibility questions, genetic uncertainties, and practical limits to scaling the procedure. The public needs to understand the difference between creating a few animals whose appearance recalls the dodo and establishing a genetically diverse, self-sustaining population. We would never treat one successful surgical case as sufficient evidence that a treatment is safe for every hospital in America. Why should we apply a weaker standard to the deliberate creation of animals?

Then there is the welfare of the creatures involved in the attempt. Who counts the unsuccessful embryos? Who monitors the health of donor birds, reproductive hosts, and hatchlings? What constitutes an acceptable rate of congenital problems, abnormal development, infertility, immune vulnerability, or chronic distress? Such questions do not express opposition to science; they express a basic obligation to the living animals that science uses. Whenever a high-profile biotechnology enterprise announces a visually dramatic milestone, I want to see the quieter information as well: the denominators, the complications, the duration of observation, the independent reviews, and the criteria under which an experiment stops. Hospitals have learned, sometimes painfully, that the successful cases at the top of a presentation do not tell you whether the overall procedure is justified.

Some advocates will answer that every frontier technology involves failure. I agree. I am not proposing that research be forbidden because results are uncertain. The question is whether the uncertainty is acknowledged, bounded, and honestly reported. For de-extinction, that should mean veterinary specialists and independent animal-welfare experts are involved before the first highly edited animal is born, not brought in afterward to bless an achievement. It means setting standards for housing, feeding, behavioral enrichment, physical health, and long-term reproductive care. It means a published plan for what happens if an animal develops a painful condition, proves unable to breed, or exhibits instincts that confinement cannot satisfy. If a company is serious about restoring a lost species, it must be just as serious about caring for each animal that cannot fulfill the larger ambition.

A related issue is the temptation to read external resemblance as proof of identity. We have already watched a public dispute over animals promoted as revived dire wolves, even though scientists identified them as gene-edited gray wolves rather than recreated members of the extinct species. That distinction is not a pedantic argument over a label. It determines what biological claims have been established and what ecological expectations can be justified. A large white wolf with certain ancient-looking features is not necessarily equipped to occupy the ecological role of an Ice Age predator. A bird with a dodo-like beak and body would not necessarily possess the dodo’s behavior, disease resistance, reproductive habits, or ecological relationships. If we cannot answer those questions, we should name the organism accurately as an engineered proxy and keep investigating.

I also worry about learned behavior. In human medicine, rehabilitation is not an optional step after a successful procedure. The patient’s ability to function matters. In a wild animal, functioning includes finding food, avoiding danger, selecting appropriate habitat, choosing mates, tending young, and interacting with other species. Some behaviors may be innate; others depend on parents, flock members, or environmental learning. No living dodo can demonstrate how a young dodo should behave. Surviving related birds provide clues, but they are not interchangeable tutors. Scientists would therefore need a defensible behavioral-development program, designed to test whether an engineered population can cope with conditions beyond a managed enclosure. Animals raised safely in captivity can become helpless when confronted with threats they have never encountered.

The proposed destination matters just as much. Mauritius is not an empty laboratory waiting to be populated. It is a sovereign island nation with communities, conservation priorities, agricultural interests, tourism, and ecosystems profoundly altered since the dodo disappeared in the seventeenth century. Habitat loss and introduced predators were part of the original story; those problems cannot be undone by editing a genome. Releasing an engineered bird into a landscape still vulnerable to invasive mammals would be an expensive and possibly cruel demonstration that the reason for extinction remains. Scientists need to establish whether sufficient habitat exists, whether the food web can support the population, which diseases or predators threaten it, and whether the release might harm existing species. The government and people of Mauritius must have real authority in every decision, not just a seat in promotional photographs.

From the perspective of hospital operations, I find the word “follow-up” especially important. A press conference occurs once; care continues for years. If an engineered population were eventually released, someone would need to track survival, reproduction, genetic changes, disease, animal behavior, and unintended effects on plants and other wildlife. Monitoring must be capable of detecting problems that appear several generations later. There must be a mechanism to intervene when things go wrong, along with a clear division of responsibility for the costs. A launch budget is not an operating budget. If a company provides the animals and then loses funding, is Mauritius expected to maintain the program? If researchers depart, who retains the records, the equipment, and the expertise? These are not bureaucratic details. They determine whether an experiment remains humane after attention has moved elsewhere.

One appealing argument for de-extinction is that the technical work may help species still alive. Gene editing, cell preservation, reproductive biology, and genomic analysis might improve conservation outcomes for endangered animals. I regard that possibility as a genuine reason to support carefully designed research. But the transfer of benefits cannot simply be asserted. Show which techniques are adaptable to threatened species, demonstrate that they improve reproductive success or genetic diversity, and identify how conservation groups can afford to use them. If the technology advances while ordinary conservation organizations lack staffing or access, then its value may be largely confined to those able to commission spectacular projects. Medical innovation faces the same problem: a treatment that exists only for patients near a prestigious medical center does not automatically solve a public-health problem.

There is also an opportunity-cost question, but it should be handled carefully. A private investor may finance a de-extinction project with money that would never have been given to traditional conservation. We cannot claim that every dollar invested in biotechnology has literally been taken from a wildlife refuge. Yet scarce scientific talent, permitting capacity, laboratory resources, philanthropic attention, and public credibility are all real constraints. If a successful publicity campaign persuades people that extinction is reversible, it could weaken support for preserving endangered species while they can still be saved. Conversely, the spectacle might inspire new donors who otherwise would not care about biodiversity. Both effects are possible, and both should be measured instead of assumed. Even an appealing narrative can have consequences that are not obvious at launch.

What bothers me most is the possible creation of a two-tier moral system for wildlife. A charismatic species with an irresistible story may attract enormous technical resources, while an unglamorous endangered reptile, insect, or plant remains unnoticed. Hospitals know a version of that problem: new buildings and celebrated procedures raise money, while appointment access and basic staffing struggle for attention. We must not organize conservation around the animals that make the best videos. If the dodo becomes a catalyst for protecting Mauritian forests, addressing invasive species, and strengthening local science, that would count in its favor. If it becomes a permanent high-maintenance exhibit while threatened living species lose ground, we should be willing to say that technological brilliance has not translated into public benefit.

Scientists should also confront the problem of genetic diversity. A breeding population cannot be built responsibly by repeating the same narrow set of inherited variations indefinitely. Low diversity may increase vulnerability to disease or reproductive problems and reduce adaptability to environmental change. Ancient specimens may provide some information about past variation, but reconstructing a species’ population-level genetic history is a different challenge from producing a single reference genome. Researchers need to establish how many unrelated founders could realistically be produced and how genetic management would function for many generations. A living creature in an enclosure can be healthy and still be part of a population with no viable future. That would be a remarkable achievement in animal production and a failure by the standards of ecological restoration.

Finally, a useful approval system should distinguish among research, captive demonstration, and environmental release. Those are three different proposals, with very different levels of risk. Investigating gene function in cells may be justifiable long before breeding an engineered bird. Producing a small number of animals in an accredited, well-monitored facility may be defensible long before any proposal to release them. Environmental release deserves the highest threshold because consequences may extend beyond the researchers’ property and control. That is not hostility to private innovation. It is recognition that a decision affecting public ecosystems belongs to the public authorities and communities that will live with its consequences. A medical device cleared for one use is not automatically approved for every other use; biological releases demand similar discipline.

I would ask for a plain-language dashboard of milestones before anyone celebrates the dodo’s return: verified genome comparisons, reproducible editing, healthy development, long-term animal-welfare data, normal fertility, sufficient founder diversity, behavioral competence, restored habitat, disease assessments, local consent, ecological monitoring, funding commitments, and independent authority to halt the program. There should be room for optimism at every stage without pretending that any stage completes the mission. The International Union for Conservation of Nature has long urged careful treatment of these projects as efforts to create ecological proxies, with demonstrated conservation benefit and serious attention to existing wildlife. That is a sensible starting point because it defines success by what the animals do for an ecosystem, not by whether they resemble a museum illustration.

I think the impulse behind this work contains something admirable. Human beings helped destroy the dodo, and it is not unreasonable to want to repair damage for which our species bears responsibility. But responsibility requires patience and humility, neither of which fits neatly into a product-launch video. We have to ask who bears the risks, who cares for the creatures, who measures the results, and who remains accountable after the excitement has passed. My answer is not that scientists should abandon de-extinction. My answer is that they should earn the privilege of moving from laboratory possibility to living population one transparent, independently verified step at a time. In medicine the patient is more important than the procedure. In conservation the animal and the ecosystem must be more important than the announcement.

Dayton, Ohio Correspondent

When someone from the laboratory tells me a difficult problem has been solved, my first question is which problem. I work in manufacturing and process engineering, where a prototype can perform exactly as intended while the production system surrounding it remains nowhere near ready. We can make a component once, in perfect conditions, with our most experienced people standing around the machine. That does not mean we can make it reliably, document every variation, keep it within tolerances, and produce enough of them to meet demand over years. The distinction sounds unromantic, but it is the distinction between an experiment and an industrial capability. I think the same confusion is threatening the public discussion of de-extinction. Scientists may be approaching remarkable milestones in recreating traits of extinct animals. Those milestones deserve attention. They do not by themselves establish that we can rebuild a species, much less restore its ecological function.

The dodo is a useful test case. Colossal Biosciences now reports advances using an AI platform to identify likely genetic targets and compare the bird’s extinct morphology with living relatives. It has discussed reconstruction of most of the dodo genome and work on the Nicobar pigeon. This sounds like the front end of a sophisticated engineering program: gathering a reference design, characterizing the available material, identifying features believed to control the desired result, and designing a route to manufacture. It is a substantial achievement if the comparisons are sound. It is not the equivalent of a released production drawing. The old organism cannot be disassembled and measured by contemporary standards. Its DNA is incomplete, its development cannot be observed, and no living dodo exists to answer questions about growth, immunity, behavior, or reproduction. The team must infer a great deal from limited evidence.

Inference can be powerful, but it creates uncertainty that engineers must manage rather than conceal. An AI model can associate a genetic change with a beak shape or limb characteristic, just as a model can suggest a promising parameter for a manufacturing process. The proposal still must survive experimental verification. A gene may influence more than one trait. Several genes may interact in unexpected ways. A change that produces the desired outward appearance may alter metabolism, fertility, or susceptibility to disease. And the effects may appear only at a later stage of life. People unfamiliar with these systems may imagine gene editing as changing a line of text in a document. Living organisms are not documents. Alter one part of a complex control system and the effects can ripple through development. The correct mindset is a disciplined series of tests, not confidence because the software produced a plausible candidate.

I would begin with specifications. What exactly does the project propose to deliver? An individual resembling the dodo in body shape? A bird with a substantial set of historically informed genetic variants? A captive breeding line? Or a self-sustaining population that performs recognizable functions in the forests of Mauritius? Those objectives are not equivalent, and we ought to stop treating them as interchangeable. In a plant, you cannot change the acceptance criteria after inspection to make an imperfect lot seem acceptable. Nor should we allow a conservation project to announce victory under whichever definition happens to fit the latest result. Define success before the experiments, and define the evidence that will disprove the claim. That protects researchers as much as it protects the public, because extraordinary results can then be reported without the burden of proving more than they actually show.

The term “proxy” strikes me as more technically honest than “resurrection.” The International Union for Conservation of Nature uses it to describe an organism intended to approximate the ecological role of an extinct species. A proxy may have value without being identical to its vanished counterpart. We accept substitutes in engineering all the time when they meet essential functional requirements. A replacement material need not have the same microscopic composition if it performs safely over the required life. But no responsible engineer confuses similar surface appearance with demonstrated functional equivalence. We test fatigue, corrosion, temperature cycling, manufacturing variation, and failure behavior. With de-extinction, the analogous questions concern life history, reproduction, food sources, disease tolerance, social behavior, and interactions with other organisms. The comparison is useful precisely because it tells us how much testing remains.

The 2025 controversy surrounding the purported return of the dire wolf demonstrated the need for this discipline. Colossal engineered gray wolves with selected traits associated with the extinct dire wolf and presented the work as de-extinction. Critics pointed out that these animals remained modified gray wolves and that visually notable characteristics did not establish restoration of the ancient species. I do not dismiss the accomplishment. Getting multiple edits to work in a developing mammal is impressive, as is producing apparently healthy offspring. But a machine that looks like a historic locomotive is not automatically equipped to haul the same load, on the same grade, in the same conditions. If the company wants to call its animals functional proxies, it should establish the functional requirements and report where they have and have not been met.

Now consider the reproductive manufacturing problem, if you will forgive the phrase. A sustainable species requires far more than a handful of successful births. It requires a repeatable means of producing healthy offspring, founder animals with enough genetic diversity to avoid a narrow breeding bottleneck, normal reproduction across generations, and facilities capable of caring for the animals while their behavior and physiology are assessed. Birds add special reproductive hurdles involving germ cells and developing embryos. Each stage can have distinct sources of failure, including edits that do not transmit as intended, developmental defects, low survival, or altered fertility. Before anyone plans a public reintroduction date, I would want to see a process map and an honest accounting of yield at each stage. How many attempts produce healthy, fertile animals? How consistent are the results? What changes have been made to the method? What is the long-term defect rate?

In manufacturing we use traceability because defects rarely respect publicity schedules. Every batch, component, measurement, and intervention must be recoverable when something fails. De-extinction projects should adopt an analogous discipline for genetic lines and animal care: documented edits, sequencing confirmation, cell provenance, surrogate history, developmental outcomes, veterinary findings, environmental exposures, and multigenerational follow-up. This is not an argument for burying scientists in forms. It is a way of learning what the experiments actually demonstrate. A program that cannot distinguish a problem introduced by editing from one caused by husbandry will struggle to improve safely. A population with poorly documented founder relationships may drift into avoidable inbreeding before its keepers recognize the danger. Good records are what turn an impressive one-time result into cumulative knowledge.

Then comes independent inspection. I do not want every laboratory to hire a government employee to stand over each instrument. I do want claims of major conservation achievement to survive examination by people who are not invested in the announcement. That can involve peer-reviewed methods, outside genomic analysis, veterinary audits, and transparent reporting of unsuccessful trials alongside successes. The point is not to embarrass private biotechnology companies. The point is to make their work credible. I have known excellent engineers who became less excellent the moment they were told a project must ship by Friday regardless of what the gauges said. Investors, board members, and media attention can produce the same pressure in biotechnology. Independent verification gives everyone permission to admit what remains unresolved.

The environmental release question is even harder because the receiving landscape cannot be reproduced on a test bench. Mauritius has changed dramatically since the dodo disappeared. Forest composition, predator populations, invasive plants and animals, agricultural activity, and human land use have all changed. An engineered bird might be fully functional inside a managed enclosure and vulnerable outside it. It could fail to find adequate food, become a prey species for introduced mammals, spread or acquire disease, or alter ecological relationships in ways nobody anticipated. Before release, ecologists must identify what the bird is expected to accomplish and compare that with less speculative alternatives. Could habitat restoration or an existing species perform the same function more safely? If so, technical accomplishment alone would be a weak reason to choose the engineered organism.

Engineers call some system failures “common-cause” failures: several components appear independent but share one vulnerability that can bring down the entire design. A new captive population might display a similar weakness if its founders come from a limited genetic base or have been raised under nearly identical conditions. One pathogen, dietary deficiency, reproductive problem, or behavioral shortcoming could affect every member. Creating more copies of a vulnerable line does not create resilience. Scientists therefore need strategies for diversity and adaptation, not merely multiplication. I would be particularly skeptical of claims based only on the health of a few attractive early animals. Healthy individuals are necessary; a robust population is the real objective. The two should be measured differently.

There is a genuine argument that new biotechnology can improve conservation for living endangered species. Better cell preservation, more accurate gene editing, and reproductive techniques could support threatened populations facing genetic problems or disease. I hope that argument proves correct. But I want the same demonstration I would demand for a new process on my plant floor: show the crossover application, establish its failure rate, and compare outcomes with existing methods. If a new laboratory procedure saves a threatened population that otherwise could not recover, then the work has delivered a conservation benefit regardless of whether anyone ever sees a dodo. If it remains confined to spectacular projects with enormous budgets and very low throughput, its practical reach may be narrower than its marketing suggests.

The cost question should be treated like lifecycle engineering, not like a ribbon-cutting ceremony. Research and development is only the beginning. A release program needs habitat preparation, veterinary infrastructure, invasive-species management, quarantine, genetic monitoring, field staff, community engagement, and long-term oversight. Each item has a recurring cost. If the animals reproduce, the costs may grow; if they fail to reproduce, extraordinary interventions may become necessary. Neither outcome is free. Ask who will own the program after the demonstration stage, where the stable financing comes from, and what conditions would trigger a pause or a shutdown. A company may finance an exciting first generation and later change its priorities. The receiving country should not inherit an unfunded obligation because no one performed a complete cost analysis.

We should also acknowledge that an ecological system is not a product that can be recalled easily. If a prototype industrial component fails, it may be isolated and removed. If a released organism breeds, disperses, exchanges pathogens, or changes the behavior of other species, reversal may prove difficult or impossible. That is why the burden of proof should increase with the ability to affect the wider environment. Contained cell studies warrant one level of review. Captive breeding warrants another. Releasing an engineered animal into a complex island ecosystem warrants extensive independent analysis, local permission, and a plan for detecting and addressing harm. Environmental uncertainty is no excuse to ban every experiment, but it certainly is a reason not to treat all experiments as having the same risk.

Our children will have strong feelings about this subject. Mine would love to see a dodo walking around again. I would probably join them. Curiosity is not a vice. It motivates careers in biology and engineering and makes people care about places they will never visit. But the educational story ought to include the difficult parts: why the bird disappeared, why its old habitat cannot simply be recovered, how much scientists still do not know, and why preserving a living species is usually easier than reconstructing one after its extinction. A child can handle the truth that science is an ongoing inquiry rather than a collection of final reveals. In fact, telling that truth may produce a better scientist.

I would propose a set of explicit engineering-style gates for the dodo project. The first would validate genomic reconstruction and the relation between edits and target traits. The second would establish healthy and reproducible development. The third would test fertility and welfare over enough time to observe delayed problems. The fourth would establish diverse founder lines and behavioral competence. The fifth would independently assess habitat, disease, invasive species, community consent, and alternative conservation strategies. The sixth would authorize only limited, monitored field trials with predetermined stopping rules. No gate should be passed because the next announcement has already been scheduled. Every gate should have owners, evidence requirements, and a clear record of unresolved issues.

I see no contradiction between admiring what Colossal is trying to accomplish and refusing to declare the problem solved. Much of the best industrial progress comes from people who attempt what others consider impossible. They succeed because they replace excitement with measurement once the experiment begins. The de-extinction industry will earn lasting respect if it learns the same habit. Bring me healthy animals, transparent methods, repeatable reproductive results, appropriate habitat, and evidence of ecological benefit. Until then, I will congratulate scientists on the pieces they have mastered and insist they identify the pieces they have not. The difference between a prototype and a species is the difference between showing we can do something once and proving it can endure in the world we actually have.

Novi, Michigan Correspondent

The phrase “bring back the dodo” sounds like someone can retrieve a lost file, open it, and resume an interrupted program. If only it worked that way. I spend my days in automotive supply chains, where we sometimes discover that an excellent component is useless because a vendor cannot produce enough units, deliver them consistently, or maintain the specifications through a model year. A species is an even more demanding system. It must eventually reproduce itself without a purchasing department arranging the next shipment. It must obtain food, survive disease, maintain enough genetic diversity, and adjust to environmental changes that were not part of anyone’s test plan. To me, that makes de-extinction one of the most fascinating and most easily oversold areas of biotechnology. The dodo project has genuine scientific content. The promise that this will become a restored wild population remains a very different proposition.

We should start with the news rather than with science fiction. Colossal Biosciences has reported progress reconstructing dodo genetic information and using AI to identify edits that might give a living relative certain extinct traits. Its approach involves the Nicobar pigeon and difficult work in reproductive biology. People may fairly call this a step toward producing a dodo-like bird. They cannot fairly call it the return of a functioning species today. A genome sequence is closer to a complicated set of engineering documents than to a functioning assembly line. Its accuracy matters, but so do production methods, variation among outputs, durability, and the environment in which the final product operates. The public should hear the distinction plainly because the temptation to turn an intermediate research result into a finished achievement is tremendous.

In my trade, the first lesson is that a product depends on things outside the product. Consider an ordinary automotive sensor. The chip can be beautifully designed, yet the part can fail because of moisture, connector quality, software compatibility, supplier handling, or a technician installing it in an environment the engineers never considered. A bird depends on even more relationships. Its microbiome, food plants, predators, parasites, nesting sites, seasons, and interactions with other species shape whether it survives. Even if scientists could produce an organism whose genes and appearance closely approximated those of the historic dodo, the conditions supporting that organism could be missing. Rebuilding the animal without rebuilding its essential ecological relationships would resemble restarting a factory after every supplier and customer had moved away.

A serious restoration plan should therefore begin with a dependency map. What habitat supported the original bird, and what remains? What trees or fruits are essential, and what competing species occupy those niches? How have introduced mammals altered the risk to ground-nesting or flightless birds? Which pathogens could affect a naive new population? How would the birds obtain the behavioral skills needed to survive? Scientists need not pretend that every question can be answered beforehand. They do need to distinguish known dependencies from assumptions and establish ways to test the assumptions without imposing unacceptable risk. When someone says an ecosystem will adapt, I hear a supplier telling me that a component is probably compatible because the connector looks close enough. That may be true, but it is not a verification plan.

The genomics itself creates a second dependency problem. Modern relatives are an indispensable starting point because the original species has been gone for centuries, but a relative is not a blank platform awaiting an extinct design. The Nicobar pigeon has its own evolutionary history, physiology, and genetic architecture. Introducing edits to obtain dodo-like features may generate interactions that are difficult to predict. We cannot assume that a set of visible traits includes the immune system, reproductive patterns, metabolism, or behavior necessary for life in Mauritius. Nor can we assume that the extinct bird’s entire genetic diversity is recoverable from limited historical material. A modern engineered proxy might perform useful ecological functions; that possibility deserves examination. It should not be confused with manufacturing exact replicas of an extinct lineage.

Then comes the difficult question of scale. Suppose scientists eventually produce three healthy dodo-like birds. What have they proved? That a particular process can yield viable individuals under controlled conditions. They have not necessarily proved that the individuals can breed, that offspring inherit stable characteristics, or that enough unrelated family lines can be established to avoid severe inbreeding. In automotive terms, we have passed a prototype review, not demonstrated an assured multiyear supply. The distinction is especially important because a few charismatic animals can attract substantial media attention. Anyone who has seen a plant celebrate its first preproduction vehicle knows how much can still go wrong between that photograph and reliable output.

Biological replication is not the same as genetic diversity. If the same narrow line is repeatedly copied, the population may grow in numbers while remaining unusually exposed to disease or reproductive weakness. Scientists would have to reconstruct or design founder variation carefully, document relationships among individuals, and monitor genetic health across generations. Uncertainty about the historic range of variation adds another complication. One reference genome is not a complete record of a species’ former diversity. A population needs the capacity to respond to the future, not just a resemblance to the past. I would want to know how many independent founder lines are feasible, what disease screening is required, and how much confidence researchers have in long-term fertility before treating release as anything but a distant goal.

The direction of the technology is nevertheless encouraging. Better genomic tools, reproductive methods, and cell-preservation systems could help existing endangered species. If scientists learn to move useful genetic variation into threatened populations or improve breeding outcomes in species with very small numbers, those tools may prove much more valuable than any specific claim about restoring the dodo. We should not dismiss the research simply because its headline is theatrical. The automobile industry sometimes gets breakthroughs from projects that never become commercial vehicles. The important question is whether the resulting technologies spread to practical problems and whether their value is demonstrated independently. A technique that saves an endangered bird from disappearing would merit celebration even if no extinct animal ever left the laboratory.

There is a risk that companies build a story around a product before the customer requirement is clear. Who is the customer for a recreated dodo? A private investor interested in technical milestones? A research institution studying developmental biology? A conservation authority seeking restored ecological functions? The people of Mauritius who would live with the birds? Those customers may want different things. The investor may value a dramatic demonstration, while the local conservation manager values habitat health and an affordable, durable program. A company can satisfy the first and fail the second. The only way to keep the effort honest is to identify whose goals determine success and who has authority to accept or reject the outcome.

The government and communities of Mauritius must not be treated as the last stop on someone else’s development schedule. The island bears the ecological risks of any release and retains responsibility for land use, biodiversity, public safety, and the interests of people who already live there. Genuine partnership means local researchers participate in the science, have access to the data, and can challenge the assumptions. It means the country controls whether a release proceeds and which safeguards apply. It also means that habitat restoration can begin for its own reasons rather than being held hostage to a future engineering milestone. If forests and native species benefit before a single engineered bird arrives, that should count as success in its own right.

Supply-chain people distinguish a vendor’s promise from a validated capacity. I would ask the de-extinction industry for a similar set of measurements: sequence accuracy, edit verification, viable-embryo yield, hatchling survival, lifetime veterinary outcomes, successful reproduction, founder-line diversity, and the cost of supporting each population over time. I would also ask who independently reviews the figures. A company may not want to publish proprietary procedures, but it can still disclose enough information to show whether its central conservation claims survive examination. Keeping detailed results private while making sweeping public assertions is a poor way to build confidence in a field already vulnerable to spectacle.

Animal welfare belongs in the same system of accountability. An attempt that yields a few healthy animals after many unsuccessful embryos or unhealthy offspring should be evaluated differently from a procedure with consistently good outcomes. Surrogate or donor birds also carry risks. Those risks must be counted rather than hidden in the development budget. We would never regard a supplier’s finished parts as the entire quality record if the process created widespread waste and injury upstream. With living organisms, that upstream record matters morally as well as technically. It may be difficult to agree on an acceptable threshold for experimental harm. That is a reason for independent ethical review, not a reason to avoid reporting the denominator.

Reintroduction requires a field system no less sophisticated than the laboratory system. There would have to be suitable habitat, perhaps protected zones, management of invasive predators, surveillance for pathogens, methods for tagging and tracking, and contingency procedures if the birds struggle or affect current wildlife unexpectedly. Some effects might appear quickly; others might emerge only after multiple generations. A small early release should be designed to answer specific questions, not to produce a media event. People accustomed to product recalls may assume that a mistake can always be reversed. Living populations can spread, reproduce, exchange disease, and change ecological relationships. That raises the stakes substantially once a program leaves confinement.

The dire wolf episode offers a useful caution about terminology. The engineered animals were remarkable gray wolves carrying edits chosen to produce certain extinct-looking traits, according to researchers who examined the claims. Describing them as fully returned dire wolves invited arguments about identity that overshadowed the technical accomplishment. I do not think this confusion was inevitable. The creators could have said they had engineered a proxy with specified features and then presented the work for scientific examination. Honest naming is not the enemy of innovation. It creates a stable specification against which future improvements can be measured. Overstatement, by contrast, can make every subsequent clarification sound like a retreat even when the underlying work is advancing.

Economic scale matters as much as scientific scale. A program may be able to produce a laboratory animal at great expense while having no feasible route to build and manage a stable population. The capital cost of research should be separated from annual costs for veterinary care, habitats, genetic testing, field monitoring, invasive-species control, and local institutional capacity. A decade after release, somebody must still be paying for the responsibilities created by the program. If that somebody is a small government or conservation organization, the funding model deserves public examination. I have seen perfectly respectable projects fail because their champions paid for installation but forgot maintenance, staffing, spare parts, and eventual replacement. Wildlife restoration can fail for the same ordinary reason.

I do not assume the choice is always between de-extinction and saving living animals. Private investors may finance exotic research that traditional conservation cannot attract, and they may create technologies useful to both. But the reverse also needs consideration: researchers, donors, politicians, and the public have limited attention, and a spectacular animal can dominate a discussion that should also cover habitat loss, invasive species, and the steady disappearance of less famous organisms. A responsible company would measure and disclose both the conservation benefits it directly creates and the burdens it imposes. There is no shame in admitting that an experimental program is primarily an investment in future technology. The shame would lie in presenting that investment as an accomplished environmental rescue.

I would like my children to grow up in a world where extinct species are studied with greater understanding and threatened species have better chances of survival. If scientific progress eventually creates a healthy dodo proxy and Mauritius decides, on sound evidence, that a controlled reintroduction would help its ecosystems, I would consider that a remarkable achievement. But a meaningful victory will require something more demanding than the first successful hatching: generations of healthy birds, functioning habitat, transparent data, and a local institution capable of managing the result without permanent dependence on a distant corporation. Until then, I am happy to call the science promising and the project unfinished. A species is not merely something we can produce. It is something that must ultimately be able to supply its own future.

Wheeling, West Virginia Correspondent

I understand nostalgia better than I would like. I grew up in a place where the mills, the rail lines, the unions, the churches, and the families made up a working arrangement that seemed permanent until it wasn’t. You can still find the buildings. You can find the old photographs. You can find men who can describe the sound of a shift change as clearly as they could forty years ago. But you cannot bring the old industrial Ohio Valley back by renovating one furnace and hiring people to wear the uniforms. The system that supported it has changed. That is how I think about the plans to revive the dodo. Scientists may someday make an animal that looks remarkably like the bird that vanished from Mauritius centuries ago. The question is whether it would enter a world capable of supporting anything resembling the life that bird once lived. Memory and restoration are not the same thing.

I don’t say that to belittle the science. The advances are substantial. Colossal Biosciences says its researchers have assembled much of the extinct bird’s genetic picture and are using artificial intelligence to identify particular changes in living relatives, including the Nicobar pigeon, that may recreate aspects of the dodo. That is the kind of thing I would have dismissed as fantasy when I was young. I am glad there are people stubborn enough to attempt it. Yet we should be honest about how far the road extends between understanding an ancient sequence and producing a wild population with the same ecological functions as its predecessor. A technical breakthrough is meaningful without being a miracle. The more extraordinary the achievement, the more we need plain language that separates observation from interpretation and hope from a finished result.

The dodo carries a special moral burden because human actions helped eliminate it. It was not a creature that faded quietly into an unrecorded geological age. People arrived on an island, altered the landscape, introduced pressures the bird could not withstand, and the species disappeared. The dodo has therefore become a shorthand for the destruction human beings are capable of when they treat a living world as endlessly available. I understand why the thought of bringing it back appeals to scientists and donors. It suggests a way to correct a historical wrong. But there is a dangerous temptation in that appeal: we may be more eager to perform an impressive act of restitution than to change the ordinary habits that caused the harm. Restoring a bird while failing to restore a habitable island would be a strange form of apology.

People in Appalachia know something about environmental repair. We have mountains altered by extraction, waterways that required long struggles to improve, and towns that still live with the costs of industries that provided livelihoods for generations. The most successful restoration is rarely the most theatrical. It involves inspecting old sites, testing water, controlling erosion, rebuilding useful vegetation, and maintaining programs long after the cameras leave. No one gets a dramatic headline for preventing another small stream from being polluted. Yet it may be the work that actually changes the future. If the dodo project brings serious resources to Mauritian habitat protection and invasive-species management, that might be its greatest contribution even if the bird itself never returns. A repaired environment benefits existing species as well as any engineered newcomers.

I am especially wary of declaring that a species has returned because an animal shares some of its outward features. The dire wolf controversy should have taught us something. A company produced gene-edited gray wolves designed to express selected traits associated with a long-extinct predator. The scientific achievement was real, but the claim that the extinct species had been restored drew justified criticism. Looks do not tell the whole biological story. The same would be true of an engineered dodo-like bird. Its beak, body, and appearance might resemble the illustrations. But we have no living dodo to show us its full repertoire of behavior or its relation to other species. Creating a likeness is not automatically recreating a way of life.

That matters because a wild creature is shaped by a community, not merely by an individual genome. A bird learns where to feed, how to respond to threats, which conditions signal a change of season, and how to coexist with its neighbors. Some information is inherited, some acquired, and some arises from generations of interaction with a particular place. Those relations do not sit in a museum drawer waiting for the right scientist to decode them. If we establish a few animals in a controlled enclosure, we may be able to study their traits. We may not know whether their behavior represents the extinct species, a modern relative, or the peculiar conditions under which they were raised. The distinction is not a reason to quit. It is a reason to avoid easy claims about restoration.

The first ethical question is whether the creatures we make have been given a reasonable chance at a decent life. We cannot ask them whether they want to participate in a program designed around human guilt and ambition. We can at least require that those directing the program consider their welfare seriously. That includes the animals used in reproductive experiments, the engineered offspring, and any living species affected by later release. A process that produces numerous unhealthy animals for each successful public example must confront that cost openly. I have spent enough time around industrial safety to distrust any report that lists successful outcomes while leaving the accidents and failures in a separate locked cabinet. Progress is not an excuse to turn vulnerable lives into disposable raw material.

Industrial safety also teaches the limits of good intentions. I have known managers who cared sincerely about employees and still sent people into dangerous situations because they convinced themselves the work was too important to stop. De-extinction can acquire the same momentum. Donors are invested, scientists have spent years developing techniques, and the public has been promised a historic event. At that point admitting that habitat conditions are unsuitable or that animal welfare outcomes fall short may feel like failure. It would actually be evidence of responsible judgment. A sound program needs someone with the power to halt a release, even after everything has been built and paid for. Safety that exists only until it becomes inconvenient is not safety.

There is also a moral difference between fixing harm and claiming mastery over nature. I don’t object to human ingenuity; my life would be impossible without it. Nor do I find it persuasive to say that every human intervention in an ecosystem is unnatural. We already shape landscapes, sometimes for the better. But we should learn the difference between responsible stewardship and the belief that every damaged thing can be reconstructed to our specifications. A revived-looking bird might create the comforting illusion that extinction is a reversible inconvenience. If people begin to think we can engineer replacements for what we destroy, we may become less willing to pay the present costs of protection. A recent study of public attitudes did not find simple evidence that promises of de-extinction automatically make people more accepting of extinction. That is useful caution against exaggerating the danger. The underlying communication risk still deserves attention.

My instinct is to protect what is here before gambling too heavily on reconstructing what is gone. That is not because living species are more glamorous; usually they are not. It is because we know they exist and have functioning relationships with present environments. We can often identify direct ways to help them: protect breeding habitat, remove invasive predators, reduce pollution, manage hunting, or maintain genetic diversity. Such work can be painstaking and politically frustrating, but it is not speculative in the same way as reconstructing an extinct bird. It is worth asking whether a dollar devoted to creating a proxy could do more good improving the survival of a threatened species. That question needs a real comparison, not a moral slogan, because privately financed de-extinction research may attract resources that would otherwise never reach conservation.

One of the worst mistakes in our industrial history was leaving communities outside decisions made in their name. Companies and governments announced what would be built, closed, extracted, or replaced, then presented local people with the consequences. If there is to be a dodo reintroduction, the people and institutions of Mauritius must not be a backdrop. They deserve a decisive role in determining whether the ecological risks are acceptable, how land will be used, who receives economic benefits, and what happens if the program becomes a burden. They should have access to the scientific findings and a meaningful ability to say no. A foreign company’s financial contribution does not give it ownership of another country’s ecological future.

The word “benefit” needs careful definition. A recreated animal might draw visitors and public attention, generating economic activity and perhaps supporting conservation. It might also require expensive maintenance or divert staff from other needs. Tourism can help places that protect their natural and cultural resources, but it can also place new pressure on them. If the primary measurable benefit is a stream of visitors hoping for a photograph, we should call the project a tourism enterprise and assess it accordingly. Conservation deserves its own evidence: healthier ecosystems, improved habitat resilience, support for existing biodiversity, and a credible path to a self-sustaining population. A novelty attraction may be legal and commercially successful without qualifying as environmental repair.

No one should underestimate the uncertainties in a wild release. Mauritius has changed profoundly since the dodo lived there. Plants, predators, diseases, and human development create a landscape that its ancestor never experienced. An engineered bird might not survive or might survive in ways that damage existing ecological relationships. Both possibilities require study. Scientists should consider controlled trials, rigorous monitoring, and advance agreement on stopping conditions. They also need to compare the engineered bird with living species that could provide similar ecological functions. A restoration project cannot justify itself merely by being harder or more exciting than another approach. We should choose tools because they solve the problem, not because they make the best story about the people using them.

The genetics pose their own problems. A handful of engineered founders may share vulnerabilities not apparent in their first years of life. Over time those weaknesses might affect fertility, immune function, or adaptation. A population is not secure simply because the census says the numbers are growing. It needs healthy variation, adequate habitat, and the capacity to handle bad years. We have watched rural communities learn that lesson in another context: an economy dependent on one employer can look prosperous until the employer disappears. A wildlife population dependent on one narrow genetic line may likewise appear successful until disease or reproductive failure reveals how fragile it was from the beginning.

I am not persuaded by the suggestion that science should never attempt something because it is difficult or unusual. Some of the most important advances we rely on came from people willing to tackle problems that seemed absurd. The laboratories exploring ancient DNA and reproduction may produce knowledge that helps animals currently at risk. If that happens, we should say so and make the techniques accessible to ordinary conservation programs where possible. But we should also refuse to allow useful spinoffs to substitute for evidence about the main project. A technology can have a valuable application without making every proposed deployment wise. That is true in medicine, manufacturing, mining, and wildlife conservation.

There is one question I would ask every person promising that extinction can be undone: what happens after you are gone? Not after the launch, but after the chief scientist retires, the company changes owners, the grant expires, and the visitors stop arriving in such large numbers. Can local authorities maintain the habitat? Can the animals reproduce without perpetual laboratory intervention? Are veterinary records, genetic data, and management plans held in institutions that will endure? Is someone obligated to pay for problems that surface a generation later? Those are the questions that distinguish stewardship from spectacle. It is not enough to give life to a creature if no one has planned responsibly for the life that follows.

The dodo’s story should make us humbler, not merely more technically ambitious. People once failed to notice that ordinary acts of colonization, introduced animals, and land use could eliminate a species. Today we have the benefit of that knowledge. We do not have to repeat the mistake by assuming that an ambitious correction cannot create fresh problems. I hope the research succeeds in the ways that matter. I hope it improves the fate of species still struggling to survive. And perhaps one day a healthy population of engineered birds will live in a carefully restored part of Mauritius with the informed blessing of its people. If that happens, I will admire the scientists. But I will admire the patient caretakers of the land at least as much. The dead world cannot simply be brought back. The living world can still be cared for, and that is where our first obligation belongs.

Tyler, Texas Correspondent

A fellow can insure a warehouse against fire and still not be able to tell you whether the owner knows how to keep the sprinklers working. I have spent years talking with contractors, doctors, churches, and business owners who want protection from things they would prefer not to think about. Some have thought hard about the risks. Others want a policy that makes the uncomfortable questions disappear. That is what concerns me about de-extinction. There is a tendency to talk as though the serious question is whether a laboratory can produce an animal resembling the dodo. The more serious public question is what happens when that animal is alive, reproducing, interacting with a landscape, and creating obligations for people who were not in the room when the project was approved. I like scientific ambition. I also want somebody to identify the party responsible when ambition encounters reality.

The new work by Colossal Biosciences deserves respect. Using genetic material, comparative biology, and an AI platform intended to identify promising edits, the company is moving toward the possibility of producing a dodo-like bird from a living relative. The project remains experimental. It has not established that a revived wild population can exist in Mauritius, where the dodo vanished centuries ago. That distinction should be in the first sentence of every public discussion. There are many steps between discovering that a technical process might work and placing the consequences in the hands of a community. I watched local developers present elegant drawings to a planning commission without adequately considering roads, water, drainage, schools, or emergency response. The drawings were not false. They were incomplete. Scientific presentations can be incomplete in exactly the same way.

Start with the simplest question: what is the insured event? Suppose an engineered bird escapes a research enclosure and establishes itself somewhere unintended. Suppose a reintroduced population carries or becomes unusually vulnerable to a pathogen that affects other birds. Suppose the animals disturb existing habitats or require continued intervention because they cannot survive otherwise. Perhaps none of those things will happen. But a responsible project must describe foreseeable losses before they occur. That involves ecological risk assessments, veterinary plans, containment measures, and clear legal authority. A conservation program should not expect the public to accept a generic promise that science will handle problems as they arise. Science is not a legal entity that can be served with notice or required to pay a claim.

Who bears the liability also depends on who controls the decisions. Is the laboratory responsible for genetic or developmental defects? Is a conservation organization responsible for releasing animals into unsuitable habitat? Is the host government responsible for approving the program despite known risks? If a third party suffers an economic loss, who receives the complaint and who pays for investigation or remediation? These questions do not require hostility toward the researchers. They require contracts, regulatory clarity, financial reserves, and a division of responsibilities established before release. I have seen too many commercial arrangements in which every participant claims credit for the project until a problem arises, when suddenly no one had the authority to prevent it. A new organism released into the environment deserves better planning than a shopping-center drainage ditch.

Then there is the difficulty of measuring the risk. An insurer can estimate losses from fires or vehicle accidents because a substantial history exists. For an extinct-species proxy, we have little or no comparable experience. A newly engineered organism may develop traits or interactions that are poorly understood. Some problems could appear after several generations. An island ecosystem might respond in unexpected ways. Ordinary actuarial thinking becomes less useful when neither frequency nor severity is well established. That is not proof the activity must be prohibited. It is a reason to distinguish insurable risks from uncertainties that belong with the project sponsors and the public authorities deciding whether to proceed. Calling something low risk without an evidence base is not the same as showing it to be low risk.

The promoters will say that careful controls can manage uncertainty. I hope so. They should specify the controls. Initial experiments could remain in secure facilities with independent oversight. Animals could be monitored for health, fertility, behavior, and possible disease transmission. Scientists could evaluate whether enough genetic diversity can be established to support a population rather than a handful of display animals. Conservation authorities could study habitat and invasive species before considering any release. Each stage should have criteria that must be met before the next. The International Union for Conservation of Nature’s guidance on creating proxies of extinct species provides a reasonable framework: demonstrate a conservation benefit, compare alternatives, consider welfare and local consent, and establish long-term monitoring. None of that strikes me as radical. It is what we would expect of a reasonably managed enterprise.

I also want to know whether the animal is what the label says it is. The engineered dire wolves that made headlines in 2025 were, according to critics and the company’s own scientific descriptions, gray wolves modified to express selected traits associated with an extinct species. That is impressive work. It is not a reason to retire distinctions among species, proxies, and engineered organisms. In insurance, the description of what you have matters. A company cannot insure one kind of operation and quietly substitute a very different operation because the buildings look similar from the road. De-extinction ought to use words with the same discipline. If the organism is a proxy, say proxy. If the ecological function is hypothetical, say hypothetical. The public has enough reason to doubt institutions without scientists giving it another reason through marketing shortcuts.

The next question is whether the host community has agreed. Mauritius is not a preserve owned by an American biotechnology company. It is a country with its own people, laws, economic interests, and wildlife management needs. Even if government officials welcome research cooperation, public legitimacy requires a meaningful process for affected residents and conservation groups. Farmers, landowners, tourism operators, and nearby communities may experience the consequences of a release. They deserve understandable information about what is proposed and an honest ability to object or suggest changes. In local government I learned that a legally adequate hearing is not necessarily the same as public consent. It is possible to comply with every procedural requirement while failing to answer the questions people actually asked.

Money complicates consent. Suppose a foreign company offers funding for habitat restoration, scientific training, and tourism opportunities. Those are genuine benefits, and the island would be foolish to dismiss them merely because the company expects something in return. Yet the arrangement could also create pressure to approve release before the risks are understood. Local institutions may come to depend on the funding. Researchers may feel that rejecting the next phase threatens valuable conservation work. That is why an agreement should separate support for existing biodiversity from permission to release engineered animals. Mauritius should not have to choose between protecting its living species and accepting the sponsor’s preferred timetable for the dodo.

The private-versus-public funding argument deserves care. Some critics say every dollar used in de-extinction should instead go to saving species that remain alive. I understand the sentiment, but a private investor does not keep a conservation budget in a drawer that critics can reassign. Much of the money might otherwise go to entirely different ventures. New attention to a vanished bird could attract people who have never donated a dime to wildlife protection. The technology might also yield reproductive or genetic methods useful to endangered animals. A blanket dismissal would therefore be foolish. But public money, public land, and public guarantees should face a sharper test: what benefit is expected, what alternatives were considered, what risk remains, and who is accountable if the program disappoints?

Even private money can create public obligations. If a company gives a city an expensive attraction that requires constant upkeep, the gift may become a liability. I have seen versions of that problem in local projects. The donor pays for the building; taxpayers inherit maintenance and staff. A dodo reintroduction could present the same issue in a more complicated form. Laboratory equipment, animal-care facilities, quarantine procedures, field patrols, habitat management, and scientific monitoring all cost money after the unveiling. If a program needs ongoing support for twenty or fifty years, it should have a financing plan for twenty or fifty years. If no such plan is possible, the project may be better treated as research in managed facilities rather than as environmental restoration.

Someone should also establish criteria for an unsuccessful result. This is an awkward subject because it sounds like planning to fail. I call it planning not to make a failure worse. What if the animals cannot breed naturally? What if unforeseen health conditions arise in the second generation? What if invasive predators remain too abundant to allow survival without intensive management? What if an introduced proxy creates ecological damage that scientists did not anticipate? Will managers reduce the population, suspend further release, bring animals back into captivity, or terminate the program? Who makes that decision, and what authority allows them to act? A stop-loss provision may not prevent every disaster, but the absence of one makes avoidable losses more likely.

There is a moral issue beneath all this accounting. The animals themselves never signed the agreement. Every engineered chick or surrogate bird bears the direct biological consequences of the experiment. Veterinary specialists and animal-welfare experts should have authority independent of the project’s publicity and financial interests. The number of unsuccessful reproductive attempts matters. Chronic illness matters. Behavioral distress matters. Creating a beautiful animal that cannot live a normal life would be a failure, even if the technology became commercially valuable. My business world is full of arguments about whether a risk is contractually transferred. Suffering cannot be transferred by a clever clause. It must be prevented where possible and acknowledged where prevention fails.

I am not convinced that de-extinction necessarily causes people to become careless about protecting existing wildlife. A published study of attitudes in 2026 found no simple evidence that promises of revival made participants more willing to accept extinction, though beliefs about the technology still mattered. That ought to humble both sides. We should not invent a public moral collapse to defeat a scientific project. We should also not assume that a moving advertisement will improve conservation decisions by itself. The right question is what people actually do: whether they support habitat protection, whether they understand the limits of the technology, and whether governments continue enforcing the rules that protect species before they disappear.

A sensible governance system would create three distinct approvals. The first concerns laboratory research: are the techniques scientifically sound and are animal-welfare standards met? The second concerns breeding and maintaining captive organisms: can the program provide reliable care, protect workers and neighboring wildlife, and report outcomes accurately? The third concerns environmental release: is there demonstrated ecological value, a defensible management plan, local consent, adequate funding, and independent oversight? Passing the first stage should not entitle a sponsor to the second, and passing the second should not create a presumption that release is inevitable. Regulatory stages lose their purpose when the eventual decision is treated as promised from the start.

It would be reasonable to require a financial assurance mechanism before any release. That might take the form of a funded reserve, enforceable insurance where coverage is available, a bond, or another arrangement appropriate to the risks and local law. Its purpose would be to ensure that the party pursuing the project cannot walk away and leave taxpayers with all the costs. The amount and structure would need careful analysis because long-term ecological liabilities are difficult to price. The key principle is simple: benefits and responsibilities should travel together. If a project sponsor keeps control of the decision and publicity, it should accept a substantial share of the consequences.

I would also require regular public reporting in ordinary language. How many animals were produced? How many survived? What unexpected traits appeared? How diverse are the breeding lines? What is happening to existing wildlife? What has been spent, and what remains funded? The report should include failures, not merely accomplishments. I would rather read a candid account of a stalled experiment than another glossy promise that a miracle is right around the corner. Real confidence grows when institutions show they can recognize inconvenient evidence and act on it. That is how a reliable business maintains customers, and it is how a high-stakes conservation project should maintain public trust.

I hope the science advances. I would like my children to live in a time when human ingenuity can repair more of the damage previous generations inflicted. But there is a difference between taking responsibility and simply acquiring the power to manipulate what we once destroyed. Responsibility includes the animals, the land, the people who live there, and those who will inherit the result. The people developing the dodo should be free to investigate difficult ideas; they should not be free to assign unpriced risk to an island community merely because their intentions are attractive. Show me the evidence, the approvals, the contingency plan, and the people who will answer the phone when something goes wrong. Until then, I am interested in the project but unwilling to sign off on its release. Somebody has to name who pays.

Bismarck, North Dakota Correspondent

There are places in North Dakota where you can drive for a long while and see what looks like nothing more complicated than grass, sky, and a few fences. Spend some time with the people who work that land and you discover a very complicated system: soil, water, grazing, insects, birds, weather, the timing of planting and cutting, and a hundred decisions that cannot be made from an office two states away. Ecologists know this, of course, but the rest of us have a habit of speaking about habitat as though it were a container. We imagine we can improve the container, put an animal inside, and declare the job complete. That is the assumption I most want to challenge in proposals to bring back the dodo. An engineered bird may eventually be possible. Building a place where that bird can live, reproduce, and interact safely with everything already there is a different and perhaps greater undertaking.

The recent announcements from Colossal Biosciences are worth reading with an open mind. The company reports genetic progress on the dodo and is using AI to identify changes associated with particular anatomical features. It proposes to work through living relatives such as the Nicobar pigeon and is discussing the longer-term ecological setting with partners in Mauritius. This represents an ambitious combination of genomics, reproduction, and habitat planning. I see no reason to sneer at people doing difficult science. But as someone who has worked around energy permitting, agriculture, land use, and community concerns, I am wary when a project appears to have solved the technical problem before anyone has established what the land can reasonably support. You may be able to engineer the bird in a laboratory. You cannot engineer centuries of ecological history back into existence by pressing a button.

Mauritius has its own history, its own land pressures, and its own conservation priorities. The original dodo lived in a particular ecological community before human settlement and introduced animals transformed the island. A flightless or relatively defenseless bird entering today’s landscape would confront different predators, vegetation, disease pressures, and human activity. The fact that the old species once lived there does not prove the landscape can support an engineered proxy now. Restoration may require long, expensive work against invasive species and for native habitats, undertaken for the benefit of existing wildlife as well as any future release. If that habitat work is not justified independently, I would be reluctant to call the eventual introduction a conservation project. Releasing an animal into conditions that repeat the original threats would not repair history; it might simply rehearse it.

The central ecological question should be function. What did the dodo contribute to the forest? Did it disperse particular seeds? How did it interact with plants, soil, competitors, and other animals? Which of those relationships are well supported by evidence and which remain educated hypotheses? If researchers cannot specify a missing ecological function and explain why an engineered bird would perform it, then the case for release is weak even if producing the animal becomes technically routine. An organism can be fascinating without being ecologically necessary. A zoo or research facility can provide a legitimate home for an animal whose scientific purpose is observation. A release into the wild requires a separate argument. The International Union for Conservation of Nature’s guidance on extinct-species proxies emphasizes this distinction for good reason.

I also think we should be careful about the word “natural.” The landscapes I know have been managed by human beings for generations, including Indigenous communities long before the present governments existed. We cannot avoid interventions simply by refusing to acknowledge them. Sometimes we burn land to sustain a healthy ecosystem; sometimes we restrict grazing or remove invasive species; sometimes we introduce animals that once belonged there. Such measures can work. But they work best when they are guided by detailed local knowledge and ongoing adjustment. De-extinction would be an unusually uncertain intervention because the released animal would not be a familiar member of the current ecosystem, and its traits might differ from those of the original species. That does not automatically disqualify it, but it raises the burden of proof.

The science needs humility for another reason. Scientists can reconstruct ancient genetic material and identify plausible edits, yet genetics alone does not guarantee a mature animal with the intended physiology or behavior. Some traits result from interactions among many genes and environmental conditions. Reproductive processes, developmental biology, and epigenetic influences add complexity. The program would also have to produce enough healthy, fertile individuals to form a diverse population. A small number of genetically similar birds would be vulnerable to problems that might not appear until much later. We should not mistake the first successful hatching, if it happens, for evidence that an entire species has been restored. A population capable of adapting to changing environmental conditions is a much higher standard than a few healthy animals living under expert care.

In the Plains we watch weather make fools of neat long-term assumptions. A habitat may appear adequate for five good seasons and fail during one extended drought or an unusually severe series of storms. Mauritius faces different hazards, but the principle is the same. A release program must plan for variable conditions, including climate change, extreme weather, disease, and unexpected shifts in food availability. It should not be designed around an ideal-year portrait of the landscape. Researchers need to know whether a population can withstand difficult years without emergency intervention or whether it will remain dependent on people forever. If perpetual management is required, the program may still have value, but the claim of a self-sustaining restoration would need qualification.

My work in compliance has taught me that environmental review often goes wrong at the point where decision-makers treat consultation as something to finish rather than as something to learn from. I would want Mauritian researchers, habitat managers, local communities, and the relevant authorities involved from the beginning. People who know the forests, the farms, and the threats to present wildlife should have the power to challenge assumptions and affect the design. An international company cannot simply arrive with a perfected organism and ask an island to accommodate it. Permission must be meaningful, informed, and capable of being withheld. If certain communities bear disproportionate risk or costs, that must be addressed directly rather than dismissed as fear of innovation.

The financing matters. Restoring habitat and managing invasive species requires people on the ground for years. Removing a threat once does not mean it stays removed. Monitoring animal populations likewise cannot be done by a single annual visit. Somebody must maintain records, equipment, biosecurity procedures, veterinary capacity, and the physical landscape. Those are operating expenses, not one-time discoveries. When government agencies or conservation organizations accept a partnership, they need to know how responsibilities will be financed if private funding changes or public excitement fades. I have seen projects with excellent engineering plans fail because nobody adequately budgeted for operations. The same mistake in a wildlife program could damage both the animals and the institutions expected to care for them.

There is room for optimism about technical spillovers. Gene-editing tools and reproductive science may help threatened species that still exist. I find that application more immediately compelling than the dodo itself. If scientists can preserve useful genetic diversity or improve breeding in a population on the edge of collapse, that could have tangible conservation value. Yet the claim should be tested with the species concerned, not inferred from progress on a charismatic reconstruction. A technique may work well in one lineage and poorly in another. Field conditions may overwhelm a laboratory advantage. And protecting the habitat may be the cheapest and most effective intervention. Biotechnology is another tool in the kit. It is not permission to throw away the other tools.

There is an uncomfortable question of tradeoffs. Some conservation programs are chronically underfunded, and high-profile de-extinction projects can command attention that ordinary habitat management rarely receives. But it is too simple to say that private investors should be forced to spend their money differently. Investment in exotic science might attract money that would not otherwise reach conservation, and that investment could produce useful knowledge. The sensible question is what the project actually contributes, after accounting for its costs and risks. Does it expand scientific capacity in Mauritius? Does it improve the condition of existing habitats? Are threatened living species better off? Are local institutions stronger? Those outcomes would make the program more credible regardless of whether a dodo-like bird ever roams freely.

It would also be a mistake to assume that the possibility of de-extinction will automatically make people indifferent to extinction. Human behavior is rarely that tidy. Research on public attitudes suggests no simple across-the-board moral hazard, although the way people understand the technology does matter. We should communicate its limitations honestly instead of predicting either automatic catastrophe or automatic enlightenment. If the publicity teaches children that species can be recreated at will, it is misleading. If it teaches them that extinction destroys complicated biological histories and that modern science can only attempt imperfect repairs, it may strengthen conservation values. The difference lies in how much truth we are willing to include in the story.

The experience with engineered dire wolf-like gray wolves illustrates the problem. Their birth demonstrated impressive gene-editing capabilities, yet scientific critics rightly distinguished them from actual restored dire wolves. Similarity in appearance does not settle species identity or ecological role. We should insist on transparent names because names shape policy. If an animal is described as a returned species, officials and donors may assume a conservation objective has been accomplished. If it is identified as a genetic proxy designed to test particular traits, the ongoing responsibilities remain clear. A public agency evaluating a release should not have to spend half its time disentangling what a promotional phrase actually means.

Animal welfare cannot be a footnote. Reproductive experiments may involve donor and surrogate birds, failed embryos, developmental problems, and animals that require intensive care. Researchers must document both success and failure, and the project should have independent experts able to intervene on welfare grounds. A creature engineered for an ecological purpose is still an individual creature capable of suffering. We must not justify avoidable harm by pointing to a speculative benefit decades away. Nor should we presume every unfamiliar technique is cruel simply because it is new. The responsible approach is to gather the evidence, compare alternatives, minimize harm, and acknowledge costs that cannot be eliminated.

Release planning should proceed cautiously, with staged assessments rather than a promised date. Begin by determining whether the intended conservation function is real and needed. Restore habitat and control obvious threats. Validate the animal’s health and reproductive capacity in controlled conditions. Study potential interactions with present species. Establish contingency measures that can be carried out if damage appears. Require long-term genetic and ecological monitoring and an independent review of results. The people of Mauritius should decide whether the benefits justify the remaining uncertainty. If one stage fails, the project should be allowed to stop there without everyone treating the pause as a disgrace. A stopped release can be an act of sound environmental judgment.

We also need to respect the differences between islands and the vast landscapes people like me inhabit. In a relatively contained island environment, some biological introductions have caused disproportionate damage because native species developed without particular predators or competitors. That history should create caution about adding a novel organism, even one intended to resemble a former resident. It is not enough to argue that the dodo once belonged there. The engineered bird may behave differently, and other species now occupy a changed ecological network. Effects could extend beyond the bird’s intended food plants or territory. Conservationists must examine those indirect interactions rather than focus exclusively on whether the new animal survives.

I can imagine a future in which a carefully managed, genetically diverse population of dodo proxies provides useful ecological services and becomes part of a wider Mauritian restoration effort. I can also imagine scientists discovering that the animals cannot perform the needed function safely and deciding to keep them in research facilities. Neither outcome makes the entire scientific enterprise worthless. The knowledge gained may still help endangered birds, refine reproductive techniques, or improve ecological monitoring. Our mistake would be to define success in advance as the release itself, because then everyone involved has a reason to overlook evidence that might argue against it. Better to define success as a net benefit to living ecosystems and let the observations determine the proper role of the technology.

The lesson I take from North Dakota is that land will not cooperate with our slogans. You can call a project green, revolutionary, restorative, or historic. The water and soil do not care. Neither do predators, parasites, or hard winters. Real conservation is measured in healthy habitat and resilient populations over time. If de-extinction contributes to that, I will support it. If it merely gives us an extraordinary animal in an unsuitable place, I will say the science is interesting and the conservation case has not been made. The dodo’s future, if it is to have one, begins with the conditions under which it could live. The habitat comes first, whether the announcement makes that inconvenient or not.

Orange County, California Correspondent

I work in commercial real estate analysis, and it has taught me to be suspicious of projects whose most exciting element is also the least expensive part to discuss. Developers like to talk about design, a famous architect, technology, and the way a completed building will transform a neighborhood. Eventually somebody asks about land acquisition, entitlement, utility capacity, insurance, environmental work, maintenance, and the revenue needed to keep the property operating. That is when you discover whether the project exists in the real world or only on a beautiful screen. I get a similar feeling when I hear that biotechnology may bring back the dodo. The science deserves serious attention. But creating a dodo-like animal may not be the hardest part of rebuilding a viable home for such a creature. Land, ecological capacity, and institutions could prove even more demanding.

The latest announcement from Colossal Biosciences involves AI-assisted identification of genetic targets and progress assembling information about the extinct bird’s genome. The company is exploring reproductive pathways through living relatives and discussing future conservation arrangements in Mauritius. Those are meaningful developments. No one should pretend that an engineered dodo has already hatched or that wild reintroduction is imminent. More importantly, there is no reason to suppose that progress on the molecular side produces equivalent progress in available habitat. In real estate, a project does not become feasible just because someone has a brilliant design for the building. If the site is wrong, or the essential infrastructure is absent, technical elegance will not save the investment. Nature has its own version of that rule.

Mauritius is not a vacant island awaiting a historic restoration. People live and work there. Land supports homes, agriculture, tourism, roads, and existing conservation areas. Habitats have changed since the seventeenth century, when the dodo disappeared after human impacts and introduced species transformed its environment. Scientists would need to assess where an engineered proxy could live without displacing more pressing needs or damaging existing biodiversity. There may be land that is suitable, land that could be restored at reasonable cost, and land that cannot support the proposed species without extreme intervention. Those categories must be mapped honestly. A company cannot write a conservation plan that assumes away competing land uses any more than a developer can assume that an occupied parcel will be available because the new building would be attractive.

The first economic question, then, is the cost of the ecological footprint. How much suitable habitat does a self-sustaining population need? How connected must those areas be? What invasive predators or plants must be removed, and how often must management continue? Are there buffers to reduce contact with people and livestock? Does habitat restoration create benefits for threatened living species, or is it narrowly tailored to a hypothetical future organism? These questions cannot be resolved solely by molecular biologists, however skilled they are. They require field ecologists, local planners, land managers, community representatives, and people who understand the island’s long-term development pressures. Land is not only an input on a spreadsheet. It is the place where other needs and rights already exist.

There is another issue that real estate analysts learn through painful experience: the initial capital expenditure is rarely the whole story. Suppose a biotechnology sponsor provides substantial money to restore a reserve and establish a breeding program. What is the annual expense of invasive-species control, veterinary monitoring, habitat maintenance, research staffing, and public safety? What happens after a severe storm or an outbreak of disease? What if the population grows and requires additional territory? What if it fails and needs continuing captive support? An honest financial model should address multiple scenarios rather than present a single optimistic budget. Governments and nonprofit organizations have limited capacity to absorb costs they did not create. A one-time gift should not become a permanent maintenance burden without a clearly agreed source of money.

We also need a credible definition of the project’s conservation return. A dodo-like bird might be a powerful symbol and attract international visitors. That could generate economic activity and support local conservation. But tourism income is not the same as ecological restoration. Visitors may come to see a managed exhibit even if the animals play no useful role in a natural environment. That is a legitimate commercial possibility, provided it is described accurately and the animals are treated well. If the program claims to restore ecological functions, however, the benefits should be measured ecologically. Are native plant populations recovering? Are particular seed-dispersal relationships being restored? Does the system become more resilient? Are existing endangered species helped or harmed? A thriving attraction and a successful conservation project are not synonyms.

I am sympathetic to private investors who want to pursue extraordinary technology. California has produced many industries because someone funded an idea before the commercial case looked obvious. The fact that a project is expensive, risky, or initially unconventional is not a sufficient reason to reject it. Advances in genome analysis, reproductive techniques, and cellular science may prove useful for endangered species. The company may also attract donors to conservation who would otherwise finance entirely different activities. It is therefore misleading to calculate every research dollar as though it had been taken directly from a wildlife refuge. The appropriate question is not whether the work is strange. It is whether claims about its benefits are supported and whether outsiders are asked to absorb risks they did not choose.

The private funding argument stops being complete once a project needs public approvals, public land, or long-term ecological responsibility. Mauritius has its own sovereignty and conservation priorities. A foreign firm financing research should not control the release decision merely because it owns intellectual property or pays for the laboratory. Officials and local communities must determine what happens in their environment. The terms of any partnership should distinguish intellectual property rights, data access, animal ownership, habitat management, and authority over release. These could become important if the company is sold, its investors change strategy, or disagreements arise with Mauritian partners. A conservation promise that depends on enduring goodwill but lacks an institutional structure is not a very secure asset.

There is a potential conflict between a proprietary business model and the scientific transparency needed for ecological decisions. A company may reasonably protect trade secrets associated with its editing methods. Yet public authorities cannot evaluate a release if the sponsor refuses to disclose essential information about the engineered organism’s genes, health, reproductive behavior, and likely environmental effects. Nor should independent scientists have to rely entirely on promotional summaries. Some information may be handled under confidentiality protections, but the substantive evidence must be independently assessable. A property developer cannot generally conceal a hazardous site condition because the cost of investigation is commercially sensitive. Environmental decision-making in biotechnology ought to operate on a comparable principle.

The problem of biological identity is relevant to economic value as well. The world saw this in the controversy over Colossal’s engineered dire wolf-like gray wolves. Their production was a technical milestone, but calling them restored dire wolves invited questions about whether the species had really returned. The label matters because it affects what donors, regulators, and the public believe they are funding. For the dodo, we should distinguish an engineered proxy resembling an extinct bird from a genetically and behaviorally identical recreation, which current science cannot promise. The value proposition may remain strong under the more careful description. In fact, accurate claims could improve long-term credibility because they reduce the risk of reputational damage when outside researchers scrutinize the work.

A reintroduction also introduces externalities. In economics, that means costs or benefits experienced by people or ecological systems outside the sponsor’s own accounts. Habitat restoration may improve watershed conditions, support biodiversity, and enhance tourism appeal. Those would be positive effects worth recognizing. An unexpected disease problem, damage to existing wildlife, or restriction on land use could impose negative effects. Because not all consequences can be predicted or priced, there is an argument for conservative staging, independent assessment, and financial assurance. The uncertainty does not justify pretending all projects are equally hazardous. It does justify refusing to let a sponsor count potential benefits in full while discounting possible long-term costs to zero.

What would a defensible investment case look like? I would separate it into laboratory research, captive population development, habitat preparation, limited field testing, and long-term management. Each stage should have its own budget, scientific milestones, independent review, and option to stop. The costs of unsuccessful embryos, animal-care complications, and genetically narrow founder populations belong in the analysis, not outside the accounting. The program should also compare other strategies for producing the same ecological benefits, including habitat restoration without the engineered bird or the use of existing species. If another approach costs less and produces more reliable conservation outcomes, the more spectacular technique should not receive preference merely because it is new.

Real estate markets provide plenty of examples of projects that looked profitable until their assumptions were tested against changing conditions. De-extinction faces a similar uncertainty over time. Climate, land use, invasive species, pathogens, and public priorities will not remain fixed for decades. A habitat suitable today may become fragmented tomorrow. A program relying on continued subsidy might become vulnerable during a fiscal downturn. Scientists therefore need not only an initial feasibility assessment but a resilient operating model. How would the program respond if funding fell, if a disease emerged, or if the birds required greater habitat than anticipated? What interests would be protected first when tradeoffs became necessary? If the answer is that the project would ask the public for help, that obligation ought to be acknowledged before the first release.

There is also the question of fair local benefit. A program could generate international publicity and commercial intellectual property while leaving Mauritius with the costs of managing engineered animals. That would be an unacceptable bargain. Conversely, a partnership that funds local scientific institutions, trains researchers, restores habitats, and supports locally accountable conservation could be a genuine opportunity. The terms matter more than the rhetoric of global collaboration. I would look for durable local employment, access to relevant scientific data, transparent governance, and a funding reserve under arrangements that remain enforceable if the corporate sponsor changes. A country should not have to rely on a foreign public-relations strategy to maintain control over its own wildlife.

I am particularly interested in the possibility that habitat work could begin now, without waiting for the genetics to succeed. Restoring degraded ecological areas, managing invasive species, and studying native plant communities could benefit living organisms immediately. It would also generate the baseline data needed to evaluate a future reintroduction. That is a sensible investment sequence because it creates value even if the speculative element fails. Developers call the opposite mistake building the amenity before securing the underlying site and infrastructure. Conservation can avoid it by making ecosystem improvement the first milestone and the engineered dodo an option that may or may not become appropriate later.

The public should be cautious about turning this subject into a conflict between science and environmentalism. A sophisticated conservation program can use biotechnology where the evidence supports it and habitat protection where habitat is the binding constraint. The field needs both curiosity and restraint. I would oppose blanket declarations that researchers have no right to investigate extinct-species traits. I would also oppose any assumption that investors who solve the laboratory problem have thereby earned the right to deploy engineered organisms in a living environment. Those are separate decisions with separate evidence requirements. Progress in one area should not shortcut due diligence in another.

I expect the dodo to remain a powerful scientific and cultural symbol whatever happens. There is nothing wrong with symbols so long as we remember they are not operating plans. A photograph of a living dodo-like bird might captivate millions. The real financial and environmental test would be whether the program could support a diverse, healthy population, improve an existing ecosystem, respect the rights of Mauritius, and remain properly funded once the novelty faded. I would gladly celebrate that outcome. Until then, I would direct at least as much attention to land use, invasive species, operating costs, and local governance as to genome editing. The laboratory may produce the headline. The land will determine whether the headline becomes a lasting achievement.

Billings, Montana Correspondent

After a hailstorm, the first version of the damage almost always comes from someone standing outside and looking at the roof. Sometimes the estimate is close. Sometimes it misses the compromised flashing, the water that will show up next month, or the old repair that fails under a new load. The job of an adjuster is to separate what can be observed from what is assumed and to keep asking how an apparently small problem might produce a much larger one. That habit makes me interested in de-extinction but skeptical of quick claims. Scientists trying to engineer dodo-like birds may be making real progress. It does not follow that the ecological risk of eventually releasing those birds is known, or that a successful birth establishes a successful restoration. The difficult losses are the ones that emerge after the ribbon is cut and the file is supposedly closed.

Consider what has actually been reported. Colossal Biosciences says it has advanced genetic analysis of the dodo and developed an AI tool to identify potential edits informed by comparisons with living birds. It is discussing a pathway involving the Nicobar pigeon and longer-term habitat arrangements in Mauritius. That is exciting biotechnology. But no wild dodo population has been restored, and no responsible report should imply otherwise. Even if researchers hatch an animal with the desired appearance, they will still have to investigate development, disease, behavior, fertility, and compatibility with the present ecosystem. If I inspected one apparently sound roof and announced an entire neighborhood stormproof, my license would deserve a second look. Biological claims should face an equally reasonable demand for evidence.

Risk is not merely a synonym for fear. It is an effort to identify what can go wrong, how likely it is, what the consequences would be, and what can be done before or after the event. With an engineered organism, all four questions are difficult. Genetic changes may behave as expected in one animal and differently in offspring or under environmental stress. Captive conditions can conceal vulnerabilities that appear outdoors. A population might survive but compete unexpectedly with existing species. A disease might emerge or spread in ways no one anticipated. Some outcomes may be reversible; others may not. The lack of past claims data means nobody can credibly put precise percentages on many of these possibilities. We should be able to acknowledge uncertainty without either inventing disaster or selling confidence we have not earned.

The dire wolf controversy is a useful example of why definitions matter. Gene-edited gray wolves were presented with the dramatic language of de-extinction, while scientists argued that they were proxies expressing selected ancient-looking traits rather than recreated dire wolves. I do not need to settle every taxonomic debate to see the practical issue. If a project’s basic description exaggerates what has been achieved, public trust weakens when harder questions arise. A person who buys coverage for one kind of structure expects that structure to be described accurately. Conservation authorities and local residents deserve the same honesty about the organism being proposed for their landscape. We can admire a technological feat while naming it precisely and admitting that its ecological performance remains untested.

I would divide the possible losses into categories rather than treat the project as a single undifferentiated hazard. The first concerns animal welfare: reproductive failures, developmental abnormalities, chronic illness, or behavioral suffering among the engineered birds and the animals used to produce them. The second concerns existing wildlife: disease transmission, competition, predation by or upon the new organism, and changes to ecological relationships. The third concerns people and institutions: land-use conflicts, economic burdens, tourism pressures, and the expense of long-term management. The fourth concerns public trust: exaggeration that turns a scientific program into a campaign that cannot admit mistakes. Each category calls for different expertise and different safeguards. One impressive genomic result does not resolve them all.

Before anyone talks about a public release, I would want an honest baseline of the place receiving the animal. Mauritius is not the same island it was before the dodo vanished. Its ecology has been reshaped by human activity and introduced species. A modern engineered proxy might lack defenses against present predators or might affect species that developed their own relationships after the dodo disappeared. Conservation experts would need to examine the state of habitat, plant communities, invasive threats, and disease. That work should not be restricted to conditions favorable to the project’s stated goal. A proper assessment documents inconvenient facts, because those facts are what determine whether the activity is safe and useful. You cannot adjust an insurance loss by refusing to enter the damaged room.

People sometimes argue that the dodo’s return would repair an old ecological injury. Perhaps it could perform useful functions, such as helping disperse seeds or supporting particular plant relationships. But those are hypotheses to investigate, not benefits that can simply be booked in advance. Scientists must establish what the extinct bird likely did and whether an engineered organism could do the same thing in today’s environment. They also need to consider living alternatives. If a currently existing animal can provide the desired ecological function at lower risk, why choose an engineered proxy merely because the story is more dramatic? The purpose of conservation is healthier systems, not the most difficult possible technical solution.

Another issue is accumulated risk. A few birds kept under expert supervision in a secure facility may pose relatively limited ecological danger. A breeding population released into suitable habitat would have the potential to grow, disperse, and affect more organisms over time. That is a qualitatively different exposure. Each step therefore needs a fresh assessment, not an assumption that an early laboratory approval automatically carries forward. In my work, conditions can change between underwriting a property and handling a later claim. With a released organism, both the exposure and the environment may change. Good governance should include continuing review and authority to revise or stop activities when new evidence appears.

The program should take delayed consequences seriously. An edited trait might be stable through one generation and behave differently later. A disease vulnerability might emerge only after the founder population becomes more inbred. A reintroduced bird might initially improve one plant population while reducing another. Ecological networks can shift over years, and the effect of a small early population may differ from that of a large established one. Any monitoring program that ends after a successful release photograph would be inadequate. We should plan for long-term wildlife surveys, genetic assessments, veterinary surveillance, and comparisons with control areas where possible. The purpose is to learn whether conservation benefits materialize, not merely to confirm that the animals are still alive.

The practical problem is that long-term monitoring costs money. Who funds the staff, laboratories, vehicles, equipment, and habitat work after the first decade? What happens if the corporate sponsor changes ownership or decides to invest elsewhere? An expensive engineered population could become a permanent obligation for the country hosting it. I would require a strong financing arrangement before environmental release, matched to plausible long-term scenarios rather than only to the best-case budget. If the program cannot sustain the costs of monitoring and intervention, the risk is being transferred from the people who chose it to people who may have had little influence over its design. That would be poor management even if the original science was excellent.

There is a legitimate case for allowing private research to proceed. Wealthy backers may finance experiments that ordinary conservation programs could never afford, and some of the tools could help living endangered species. We should evaluate those benefits on their merits. Better reproductive technology or genomic methods could be useful even if the headline species never returns. I do not subscribe to the claim that every private dollar devoted to a dodo would otherwise have gone to protecting a threatened bird. That is not how most investors or donors behave. Still, public agencies and scientists must account for scarce attention, staff capacity, land, and local institutional resources. The opportunity costs are real even if the accounting is more complicated than a single subtraction.

The research literature has begun asking whether de-extinction creates a moral hazard by making people less concerned about extinction. A 2026 study did not find straightforward evidence that promises of de-extinction increased acceptance of extinction, while showing that beliefs about what the technology can actually do matter. That is a useful corrective to easy arguments on both sides. We should not say the technology will necessarily destroy conservation ethics, nor that it will necessarily transform public support. What matters is how people are taught to understand the limits. A recreated-looking creature may remind us of a species we lost; it should not persuade us that all the things lost with it have been recovered.

Local consent belongs in the center of the discussion. Mauritius has its own authority, interests, and capacity. People who will live near a future release site should be told in accessible language what the organism is, what risks have been identified, what remains unknown, and who will respond to problems. They should participate before the decision is effectively made, not after the sponsor has announced a target date. An agreement that gives local authorities a ceremonial role but leaves them unable to halt the experiment would be inadequate. The people exposed to the ecological consequences must retain meaningful control over whether those consequences are accepted. That is not anti-technology. It is the ordinary practice of respecting neighbors.

Animal welfare may be the most immediately observable category of loss, yet it is often treated as incidental. Researchers must count unsuccessful embryos, health problems in offspring, effects on surrogate or donor animals, and lifelong veterinary requirements. An animal whose external features delight spectators may suffer from abnormalities invisible in photographs. Independent specialists should examine the evidence and have authority to intervene. I would be cautious about project updates that celebrate the few successful animals without providing the broader record of attempts. An adjuster who wrote a report that ignored half the damaged structure would not be praised for emphasizing the intact portion. Scientific accountability should not work differently merely because the outcome is emotionally captivating.

A good risk-management plan would use a sequence of decisions rather than a single broad authorization. The first stage would validate the genomic and reproductive methods. The second would establish whether healthy, fertile animals can be maintained with acceptable welfare outcomes. The third would evaluate population diversity, behavior, and disease resistance under managed conditions. The fourth would examine ecological benefits, alternatives, and habitat readiness. Only after those stages would a local authority consider limited release with predetermined criteria for expansion or termination. This does not guarantee success. No responsible risk analysis can guarantee that. It does make success more likely to be genuine and failure less likely to become a public emergency.

There is a final danger in romanticizing the past. Extinction can leave an image that survives long after the full ecological reality has become uncertain. We may end up designing organisms to satisfy a modern expectation of what an extinct creature should look like. AI tools can make those expectations more precise, but precision is not the same as historical truth. Fossils, fragments of DNA, and old accounts provide evidence, not an exhaustive record. Researchers should publish the uncertainty around their interpretations and distinguish directly observed traits from modeled ones. That distinction matters because it shapes both public understanding and ecological predictions. An imagined past should not be permitted to overrule the needs of the living present.

I hope the scientists continue their work, and I hope they share both setbacks and successes. But before I endorse a release, I want the loss scenarios on the table: what could happen to the animals, to present wildlife, to land managers, and to the public; who has the ability to respond; and where the money comes from when a bad outcome outlasts its original sponsor. That might sound prosaic beside the prospect of seeing a dodo again. It is supposed to. Responsible stewardship is a long sequence of ordinary decisions made before and after the extraordinary event. The public deserves more than an estimate based on a photograph of the roof.

Cedar Rapids, Iowa Correspondent

I spent much of my working life accounting for plants. You can make a set of numbers look attractive by putting a few costs in a different column, but the underlying business does not improve when you move the ink. The same rule ought to apply to de-extinction. A company promises that modern genetics and artificial intelligence may eventually recreate an animal with important traits of an extinct species. That promise deserves investigation and, where justified, investment. But we should not recognize the full benefit of restoring a species before we know whether it can reproduce, whether it can survive in a changed environment, or whether the ecosystem will improve because it is there. Those are uncertain future outcomes. The scientific achievement of making a convincing proxy would be real. The conservation value cannot be booked at the same time without evidence.

The dodo has become the public symbol of this enterprise, and it is not difficult to understand why. The bird disappeared from Mauritius centuries ago after human actions disrupted its environment. Colossal Biosciences now reports substantial progress reconstructing its genetic information and using AI to identify edits that might confer extinct traits on descendants of living relatives. I wish the scientists well. I would also like the public to understand the accounting periods, so to speak. The present stage is research. A possible later stage is production of healthy engineered birds. Another stage would be a captive breeding population. Still another would be ecological release, and after that would come decades of management and evaluation. Benefits claimed from the final stages should not be entered as realized gains during the first.

The word “de-extinction” itself creates an accounting problem because it can suggest a full reversal of loss. Suppose a century-old factory burns down and someone constructs a building on the same site with a similar facade. The replacement might be beautiful and useful, but the destroyed machines, records, workers’ skills, supplier relationships, and knowledge are not magically restored. The same is true of a vanished species. A genome may preserve or allow scientists to infer some biological information. It does not recover every genetic variant once present in the population, every learned behavior, or the relationships that evolved with its surroundings. A new organism might serve some of the old functions. It may also differ in important ways. We should give scientists credit for producing what they actually produce, without pretending the historical loss has been erased.

An economic analysis should begin by defining the objective. Is the project intended to create scientific knowledge, develop commercially useful biotechnology, produce a captive exhibit, or restore biodiversity? These aims may overlap, but each has different measures of success. Laboratory research could be worthwhile if it develops a reproductive technique that helps an endangered living species. A captive population could provide educational and scientific value without any justified plan for release. An ecological restoration program, on the other hand, must demonstrate actual net benefits to a living ecosystem. Mixing all these objectives into one glowing estimate risks crediting the same accomplishment several times. I would keep separate accounts and require evidence for each claimed result.

Next comes the counterfactual. That word sounds grander than it is. It means asking what would happen if we used the same resources differently. If the goal is to improve ecological functions in Mauritius, what could be accomplished with habitat restoration, removal of invasive species, or protection of existing threatened animals? Could a living species provide a similar ecological service at lower cost and uncertainty? If the answer is yes, an engineered dodo proxy may be a less efficient conservation instrument even while remaining a valuable research project. Proper comparisons should include the full lifecycle costs and probabilities of success, not just the price of the first animal. Spending more does not automatically produce more conservation.

There is a trap in the argument that every dollar spent on de-extinction is stolen from existing conservation. Private investors do not necessarily have an alternative plan to fund wildlife reserves. If they did not back biotechnology, they might put the money in software, property, or some other venture. The research may also attract new donations to conservation and develop tools useful to threatened animals. Opportunity costs still exist, but they must be identified rather than assumed. Scientific talent, government attention, local land, permitting capacity, and the time of conservation organizations are scarce even when money comes from new sources. I would like to see a serious estimate of those nonfinancial demands before declaring either that the project drains conservation or that it adds value at no cost.

The financial structure after the laboratory stage worries me more than the initial research spending. Successful release could require land preparation, invasive-species control, veterinary monitoring, quarantine, genetic management, ecological surveys, and trained local staff. Those expenses recur. A private company may pay for the first animals and the initial habitat work, but who pays in fifteen years? What if the sponsor’s financial condition changes? What if an unexpected disease requires a costly intervention? A useful financial plan should include a base case, downside scenarios, reserves for contingencies, and enforceable responsibility for long-term obligations. Calling something a gift does not mean the recipient can afford to own and operate it. Iowa communities have learned that lesson with more than one promising project.

One risk is that the technology performs exactly as planned and still fails the conservation test. Suppose several dodo-like birds hatch successfully and appear healthy. That would be a genuine milestone. Now suppose the animals cannot reproduce without continual laboratory intervention, cannot survive outside protected enclosures, or perform no clear ecological function. The experiment may have advanced science, but the original promise of species restoration would remain unmet. A financial analysis must avoid treating a technically successful stage as proof of an entirely different outcome. Companies may reasonably revise business plans as knowledge improves. They should not rewrite the definition of success after the fact while continuing to claim the full original benefit.

The dire wolf episode showed why such caution is necessary. Engineered gray wolves with selected extinct-like traits were publicly presented as the return of a vanished predator, and outside scientists challenged the description. It was an important demonstration of gene-editing capability. Whether the animals qualify as a recreated species is a different question, and the ecological role of the extinct predator is another question again. None can be settled merely by pointing to a photograph. In accounting, a change in label does not change the nature of the asset. The same discipline should govern biological claims. If scientists have made a proxy, let us call it a proxy and examine its properties honestly.

The animal-welfare costs also belong in the ledger. Researchers may need many attempts to produce healthy offspring; donor and surrogate animals may undergo procedures; some engineered individuals may suffer developmental or health problems. Those outcomes are not interchangeable with ordinary material waste. They impose moral costs that cannot be compensated simply by promising eventual breakthroughs. A credible program should document the number of attempts, veterinary complications, lifespan and fertility outcomes, and independent ethical reviews. If techniques improve over time, the data should show it. Hiding the failures would undermine the very scientific knowledge the investors say they are creating. We learned long ago that an honest loss report is more useful than a manufactured profit.

I would also ask about the genetic capital of the proposed population. The original dodo was not a single sequence stored in a computer. It consisted of individuals carrying variation shaped by generations of evolution. Modern researchers may reconstruct a reference genome, but that does not mean they can reproduce the former range of diversity. If engineered birds descend from too few founder lines, a population may face inbreeding, disease vulnerability, or weak adaptability. Producing many animals from the same narrow stock can increase the head count without increasing resilience. That might satisfy a superficial numerical target while leaving the supposed restoration fragile. A conservation program needs to measure genetic health and long-term reproductive capacity, not merely the number of living proxies.

The island’s environmental conditions complicate every estimate. Mauritius today differs from the place the dodo occupied, with introduced species, altered habitats, and modern human land use. A successful release would require knowing where suitable habitat exists and what threats remain. Restoring the landscape might benefit present biodiversity regardless of the engineered bird, which is a reason to do that work first. It would also provide better evidence for judging whether a proxy is necessary. If the habitat cannot be secured, the release should not proceed simply because the animals are ready. This would be the ecological equivalent of commissioning expensive equipment for a facility that has no reliable power supply.

How should we value knowledge produced by the program? More cautiously than promotional material tends to do, but not at zero. Advances in cell preservation, reproductive technology, and genome editing could help threatened living species. There may be valuable scientific spillovers even if no dodo-like bird is ever released. I would want researchers to identify those applications, publish results that can be independently examined, and demonstrate improved outcomes where possible. Scientific knowledge is often unpredictable in its future uses, so an early project need not have a perfect forecast. But unpredictability cuts both ways. We should not claim certain large conservation benefits merely because the tools might prove useful someday.

A proper comparison must consider risk on both sides. Traditional conservation projects also fail. Habitat restoration can suffer from poor planning, funding shortages, or unforeseen ecological responses. It would be dishonest to compare an uncertain new technology with an imaginary old technology guaranteed to succeed. The standard should be expected benefit under realistic conditions, plus consequences of failure. De-extinction likely has a higher degree of scientific uncertainty, but it might address a function that no existing alternative can provide. If that were demonstrated, it could deserve support. The question must remain open to evidence rather than answered by enthusiasm or hostility toward genetic engineering.

The public narrative matters financially as well as morally. Dramatic announcements can attract investors and donations, which is useful when it funds legitimate research. They can also produce pressure to continue projects that no longer meet their original goals. Economists sometimes call that the sunk-cost problem. The money already spent does not make the next dollar wise. A project should be reviewed at each stage based on what remains to be achieved and what other options now exist. If scientists conclude that engineered dodo proxies are unlikely to survive in a restored Mauritian habitat, they should be able to pause or abandon release without being branded failures. Saving future costs and preventing ecological harm would be prudent management, not betrayal of innovation.

Mauritius should maintain authority over any program affecting its environment and should benefit fairly from collaboration. Local scientists and communities need access to the relevant evidence, and funding agreements should not make the government dependent on approving release. The country may reasonably welcome private capital for restoration and research. It should be able to say no to an unsafe or unhelpful experiment without forfeiting unrelated conservation commitments. The division of intellectual property, data rights, ecological liabilities, and long-term costs should be explicit. Good governance is less exciting than a science headline, but it is one of the few reliable ways to keep a promising project from becoming a costly obligation for somebody else.

I like the idea of telling children that science can help repair damage humans caused. I would dislike telling them that extinction is a temporary inconvenience. A 2026 study did not find straightforward evidence that promises of revival automatically lead people to accept extinctions more readily, which should stop us from overstating that danger. Yet people still need to understand the difference between creating an engineered approximation and restoring an evolved lineage and its ecosystem. One phrase can encourage curiosity; another can foster complacency. Clear terminology is therefore not just academic neatness. It influences which outcomes are valued, which programs receive money, and whether the public can recognize genuine progress.

My final test is simple enough to write in an accountant’s notebook. State the objective. Count the full costs. Describe the alternatives. Identify the risks, including the ones nobody can price confidently. Specify who pays if the outcome is poor. Establish measurable conservation benefits before calling the venture conservation. Then report actual results, including setbacks, against the same definitions year after year. There may be a very good case for continuing research into the dodo, especially if it develops methods that protect species still alive. There is not yet a demonstrated case for declaring a full return from extinction. The loss was real and included far more than the absence of one familiar bird. We cannot make that loss disappear by changing the entry on the balance sheet.

Dublin, Ireland Correspondent

From Dublin, the debate over de-extinction has a familiar structure. An American technology company announces an impressive technical advance, the international press asks whether history has been overturned, and the harder questions about law, sovereignty, evidence, and responsibility arrive several paragraphs later. I work in compliance, so naturally I read those later paragraphs first. The idea of recreating traits of the extinct dodo is scientifically fascinating. It may lead to technologies that help endangered animals. But any attempt to introduce engineered birds into Mauritius would cross several boundaries: between laboratory science and ecology, between private innovation and public authority, and between a commercially owned technique and a country’s biological heritage. We should resist treating those boundaries as obstacles to be brushed aside once the science becomes exciting enough. They are part of what makes a project legitimate.

The immediate facts deserve some care. Colossal Biosciences has described significant progress in reconstructing dodo genetic information and has introduced an AI system intended to identify changes associated with the extinct bird’s distinctive features. Its proposed pathway involves living relatives, particularly the Nicobar pigeon, alongside challenging reproductive work. News accounts also describe engagement with Mauritian conservation interests over what a future habitat might require. None of this establishes that a dodo has been hatched. Nor does it demonstrate that a self-sustaining wild population could be reintroduced safely. The distance between those claims is more than academic. Each stage can carry different legal obligations, ethical questions, and environmental consequences. A permission to conduct research is not the same as permission to maintain genetically engineered animals, and neither constitutes authority to release them.

The word “de-extinction” is itself a source of confusion. The International Union for Conservation of Nature has used the term “proxy” because currently proposed methods cannot simply recover an extinct species in its genetic, behavioral, and ecological entirety. That is sensible. A genome reconstructed from ancient material may be incomplete and may not capture the former diversity of the population. Gene edits to a living relative can produce selected attributes without reproducing every characteristic of the extinct organism. Even a bird that resembles the dodo could differ in immune function, development, fertility, behavior, and environmental interactions. If the scientific evidence supports a proxy, the legal and public documents should call it one. Precision does not diminish an achievement. It protects the public from making decisions based on a promise that science has not demonstrated.

The earlier argument over engineered dire wolf-like gray wolves illustrates the cost of loose language. Colossal announced animals presented as dire wolves, while other scientists pointed out that they were modified gray wolves expressing selected traits rather than true biological restorations of the extinct species. I do not dismiss the technical accomplishment. I object to any practice that requires the public to reverse-engineer a marketing phrase before understanding the claim. Regulatory systems depend on stable descriptions of the things they are assessing. The characteristics that matter for safety must be documented even when they are less visually dramatic than the traits selected for publicity. A project cannot rely on the charm of an extinct name to avoid a detailed account of the organism it has actually created.

The first jurisdictional issue is obvious but easily overlooked: Mauritius is a sovereign state. It is not a subsidiary of a biotechnology company in Texas, and its ecological future is not a testing ground that foreign investors may direct by virtue of having financed the invention. A proposed release would require decisions made through the country’s own institutions and applicable law, supported by credible environmental assessment and informed public engagement. Local researchers and conservation authorities should participate in defining the program’s goals, not merely in implementing a design approved abroad. Any promise of economic or scientific benefits should be examined alongside risks and long-term responsibilities. Consent is meaningful only when the party being asked can actually decline without being punished through unrelated funding arrangements.

The second issue is the international character of biological research. Genetic materials, cell lines, animals, scientific data, laboratory services, and equipment may cross national borders during such a project. Each transfer can raise questions about permits, biosecurity, animal welfare, intellectual property, and access to biological resources. International agreements on biodiversity and biosafety may be relevant depending on the countries, organisms, and particular activities involved; their application should be established by qualified authorities rather than presumed from a headline. The correct approach is to map the legal pathway before expensive commitments become irreversible. Public authorities should know where materials originated, who may use them, what is being transported, and what obligations remain if commercial arrangements change.

Ownership is a particularly interesting problem. The historical dodo belongs to the natural and cultural story of Mauritius, but modern patent law and proprietary biotechnology can produce rights over specific techniques, engineered cell lines, or other inventions. I would want to see how the parties intend to distinguish rights over the technology from authority over living organisms and ecological decisions. Can a company prevent independent researchers from studying important traits? Who has access to the resulting genomic and welfare data? If a problem emerges after release, can Mauritian authorities obtain the information necessary to respond without negotiating with patent counsel? Agreements should answer those questions at the beginning. A country should not discover during an emergency that essential scientific records are contractually inaccessible.

There is also a scientific accountability question that is related to, but different from, intellectual property. A company may understandably wish to protect commercial procedures. Yet claims about public conservation benefit must be open to independent evaluation. Reviewers should be able to assess what edits were made, how the animals developed, what health problems occurred, and what ecological assumptions support release. Some information may require careful handling, but the evidence central to public safety cannot remain a matter of private assurance. It is one thing to say a company has produced an innovative platform. It is quite another to argue that other people’s ecosystems should absorb the risks of a project that outsiders are not permitted to examine meaningfully.

Environmental release deserves its own governance standard because the consequences can continue after any particular institution changes direction. A captive experiment can, at least in principle, be contained. A released organism may reproduce, move, interact with other species, and participate in disease dynamics. Even if it cannot survive on its own, it may require costly efforts to rescue or manage the population. Authorities therefore need credible baseline surveys, a clear statement of expected ecological benefits, alternatives analysis, risk assessments, and post-release monitoring. They must also decide who has the power to stop the program and what remedies are available if harm occurs. The presence of international scientists should not blur the local chain of accountability.

The habitat question may prove decisive. Mauritius today is not a reconstruction of the seventeenth-century ecosystem in which the dodo lived. Introduced species, land-use change, disease pressures, and transformations in native vegetation raise difficult questions about whether a dodo proxy could survive and what role it might play. Restoring or protecting habitats can benefit living species regardless of whether an engineered bird is ever produced. That work ought to be treated as an independent conservation objective, not simply as preparation for a product demonstration. If ecologists determine that existing species can provide a desired ecological function more safely, the engineered organism should not receive a presumption of preference. The goal is ecological benefit, not the validation of an investment thesis.

Another requirement is honest recognition of the animals’ interests. A biotechnology program might involve many reproductive attempts before healthy animals are born. Donor and surrogate birds could be exposed to procedures and health risks. Engineered offspring might face developmental difficulties that do not show in promotional photographs. The project needs independent veterinary oversight and transparent reporting of both successful and unsuccessful attempts. If welfare outcomes are unacceptable, researchers must be able to pause or end a stage despite investor pressure. The organisms are not merely samples or intellectual-property embodiments. They are living animals whose treatment must be justified on its own terms.

A program that aims at genuine restoration also needs multigenerational evidence. A few healthy engineered animals cannot establish species-level resilience. The original dodo population had genetic variation accumulated over many generations; researchers do not necessarily have access to that full record. If the modern founding population is narrow, subsequent generations could encounter fertility or disease problems. Scientists would need to monitor genetic diversity, reproductive success, physical health, behavior, and ecological effects over many years. Funding commitments must match that obligation. An initial agreement that expires soon after a celebrated release would place much of the risk on local institutions while allowing the original sponsor to claim the most visible benefit.

The European experience with regulation provides a useful perspective, though not a model to copy without thought. European debates often move between demands for innovation and concerns about precaution, documentation, privacy, or safety. Both instincts have something to offer here. Regulators should not create impossible requirements merely because the technique is unfamiliar. At the same time, the absence of a ready-made legal category for extinct-species proxies is not evidence that oversight is unnecessary. Authorities should define the actual biological and environmental risks, identify which existing rules apply, and address genuine gaps openly. International cooperation can help develop methods of assessment, but cooperation should not erode the host country’s right to make its own decision.

Funding arrangements will be as important as legal definitions. Private capital may support research that traditional conservation donors would never finance, and some of the resulting methods could benefit threatened animals. That possibility is a legitimate argument for continued work. It does not mean there is no opportunity cost. Local scientific institutions, conservation staff, land, public attention, and government approval capacity are limited. A partnership should describe what the country receives even if the dodo project never reaches release. It should fund habitat and capacity-building outcomes that remain useful independently of the company’s success. Otherwise a community may become dependent on a speculative technological milestone for work it needs now.

One frequently expressed worry is that a promise to reverse extinction will weaken public concern about species currently at risk. That sounds plausible, but plausible is not the same as established. Research published in 2026 found no straightforward evidence that de-extinction promises automatically made people more willing to accept extinctions; belief in the ability to restore species nevertheless appeared relevant. We should resist convenient stories on either side and instead communicate the limits precisely. A reconstructed-looking animal is not evidence that the original species’ complete evolutionary history has returned. Extinction continues to represent a profound loss even when technology can recreate selected traits or functions. Honest communication can make the scientific story more interesting rather than less.

I would like to see a publicly accessible memorandum agreed by the principal parties before any major release decision. It should state the proposed organism’s identity, the ecological purpose, the evidence required, the responsibilities of sponsors and host institutions, the role of local communities, access to data, long-term funding, and the authority to suspend operations. It should also explain how disputes would be handled if the original business relationships fail. That is not bureaucracy for its own sake. It is a way of ensuring that the promises made at the beginning survive the human tendency to forget inconvenient responsibilities once an exciting objective has been achieved. No international partnership should depend entirely on the continuing enthusiasm of the people who announced it.

There is a final question of legitimacy that scientists sometimes underestimate. If Mauritius eventually decides against releasing a dodo proxy, would the sponsors accept that as a successful exercise of responsible governance? Or would a decision grounded in local ecological concerns be depicted as an obstacle to progress? The answer reveals whether collaboration is genuine. A sponsor that respects sovereignty must accept that local authorities could rationally conclude that the science is impressive but the environmental case insufficient. The possibility of a lawful no is what gives meaning to a lawful yes. Without that distinction, consultation becomes little more than a ceremony held on the way to a predetermined decision.

I would love to visit Mauritius and see evidence that one of the world’s best-known losses has inspired improved conservation. I might even see an engineered dodo-like bird there someday. But if that day comes, I hope the achievement is reported with the same care that went into the research: what has been recreated, what remains different, what ecological outcomes are documented, and how the people responsible will protect the animals and the environment over time. The technology may be American, international, or increasingly global. The land is Mauritian. The laws must be respected, the science must be independently testable, and the risks must be borne by institutions that have agreed to carry them. A dodo is not a passport that allows anyone to bypass those requirements, however remarkable the experiment becomes.